Effectiveness of Dry Needling Versus Manual Trigger Point Release on Active Rhomboid Trigger Points
NCT ID: NCT07062692
Last Updated: 2025-07-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
48 participants
INTERVENTIONAL
2025-07-23
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Dry Needling and Activator Trigger Point Therapy on Upper Trapezius Trigger Points.
NCT04348097
Comparison of Dry Needling and Thera Gun Treatment on Trapezius Muscle Active Trigger Points.
NCT05090332
Dry Needling Versus Graston Technique in Active Myofascial Trigger Points on Upper Trapezius
NCT03946995
Comparison of Integrated Neuromuscular Inhibition Technique With Myofascial Release on Rhomboids Trigger Points
NCT05497856
Manual Treatment Regimens in Upper Trapezius Trigger Point
NCT04157439
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants: 48 individuals (aged 20-60) with clinically confirmed active rhomboid trigger points.
Interventions:
Group 1: Dry needling therapy.
Group 2: Manual trigger point release. Both groups receive adjunct therapies (ultrasound, cold packs, and home exercises).
Outcome Measures: Pain (Numeric Pain Rating Scale), ROM (goniometer), and function (DASH Questionnaire).
Duration: 2-week intervention with follow-ups at 1 and 2 weeks.
Significance: The study addresses a gap in evidence for rhomboid trigger point treatments, guiding clinical decisions for pain management. Results may optimize therapeutic approaches for upper back pain.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
dry needling trigger release therapy
This group will undergo dry needling trigger release therapy. Total of 2 sessions (one per week) followed by home based exercises plan. Treatment protocol of both groups will include Therapeutic ultrasound, Cold pack application and Home based exercise plan.
dry needling trigger release therapy
The dry needling intervention involved inserting sterile filiform needles directly into active rhomboid trigger points for 1-2 sessions (1 session/week) to elicit local twitch responses and relieve tension.
MANUAL TRIGGER POINT RELEASE
Manual trigger release will be given to the other group. Total of 2 sessions (one per week) followed by same home based exercises plan will be given to the both groups. Treatment protocol of both groups will include Therapeutic ultrasound, Cold pack application and Home based exercise plan.
MANUAL TRIGGER POINT RELEASE
The manual trigger point release intervention involved applying sustained pressure to active rhomboid trigger points followed by passive stretching to release muscle tension and improve mobility.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
dry needling trigger release therapy
The dry needling intervention involved inserting sterile filiform needles directly into active rhomboid trigger points for 1-2 sessions (1 session/week) to elicit local twitch responses and relieve tension.
MANUAL TRIGGER POINT RELEASE
The manual trigger point release intervention involved applying sustained pressure to active rhomboid trigger points followed by passive stretching to release muscle tension and improve mobility.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pain Level: Moderate to severe pain intensity (e.g., 4 or higher on a Visual Analog Scale or Numeric Pain Rating Scale).
* Duration of Symptoms: pain for at least 4 weeks.
Exclusion Criteria
* fibromyalgia
* Rheumatic and inflammatory disease
* Recent Surgery
* Diabatic
* Cervical radiculopathy and nerve entrapment
* Pregnancy
* Malignancy
20 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Riphah International University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amna Anum, ms
Role: PRINCIPAL_INVESTIGATOR
Riphah International University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Riphah International University, Malakand
Chakdara, KPK, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC-01017 Khaist Yousafzai
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.